77.56
price up icon0.77%   +0.59
after-market  アフターアワーズ:  77.56 
loading

Biomarin Pharmaceutical Inc. (BMRN) 最新ニュース

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript - MSN

pulisher
MSN

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday - Walmart (NYSE:WMT) - Benzinga

pulisher
Benzinga

BioMarin stock downgraded by Baird amid BridgeBio study data - Investing.com

pulisher
Investing.com

Q2 2024 EPS Estimates for BioMarin Pharmaceutical Inc. Decreased by Analyst (NASDAQ:BMRN) - Defense World

pulisher
Defense World

Amgen’s Imdelltra Becomes First Bi-specific T-cell engager for Advanced SCLC - BioSpace

pulisher
BioSpace

Biotech company lays off over a hundred Bay Area workers - SFGATE

pulisher
SFGATE

BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace

pulisher
BioSpace

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to Post Q2 2024 Earnings of $0.36 Per Share, Zacks Research Forecasts - MarketBeat

pulisher
MarketBeat

Zacks Research Comments on BioMarin Pharmaceutical Inc.'s Q3 2024 Earnings (NASDAQ:BMRN) - Defense World

pulisher
Defense World

Biopharma Layoff Tracker 2024: Bolt, Tenaya, BioMarin and More Cut Staff - BioSpace

pulisher
BioSpace

BioMarin to reduce global workforce by approximately 170 employees - TipRanks.com - TipRanks

pulisher
TipRanks

Q3 2024 EPS Estimates for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Increased by Zacks Research - MarketBeat

pulisher
MarketBeat

BioMarin: Short-Term Headwinds But Long-Term Opportunities Remain - Seeking Alpha

pulisher
Seeking Alpha

BioMarin sheds 170 jobs in wake of narrowed R&D refocus - Fierce Biotech

pulisher
Fierce Biotech

Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170 - Yahoo Finance

pulisher
Yahoo Finance

BioMarin Pharmaceutical (NASDAQ:BMRN) Now Covered by Analysts at Evercore ISI - Defense World

pulisher
Defense World

Biopharma Layoff Tracker 2024: Bolt, Tenaya, BioMarin and More Cut Staff - BioSpace

pulisher
BioSpace

BioMarin cutting about 170 jobs after shuffling drug portfolio - The Business Journals

pulisher
The Business Journals

BioMarin Pharmaceutical to lay off 170 employees (NASDAQ:BMRN) - Seeking Alpha

pulisher
Seeking Alpha

Evercore ISI Initiates Coverage on BioMarin Pharmaceutical (NASDAQ:BMRN) - MarketBeat

pulisher
MarketBeat

Analyst Ratings For Biomarin Pharmaceutical

pulisher
Benzinga

Amalgamated Bank Decreases Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

pulisher
Defense World

Benjamin F. Edwards & Company Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

pulisher
Defense World

Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Simply Wall St

pulisher
Simply Wall St

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Jean Jacques Bienaime Sells 20000 Shares - Defense World

pulisher
Defense World

Thornburg Investment Management Inc. Sells 105,276 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

pulisher
MarketBeat

Biomarin executive sells over $3.25 million in company stock - Investing.com India

pulisher
Investing.com India

Biomarin executive sells over $3.25 million in company stock - Investing.com

pulisher
Investing.com

BioMarin shares receive Outperform rating on new leadership - Investing.com India

pulisher
Investing.com India

Jean Jacques Bienaime Sells 20,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock - MarketBeat

pulisher
MarketBeat

BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Metis Global Partners LLC Sells 245 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

pulisher
Defense World

Charles Schwab Investment Management Inc. Raises Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

pulisher
MarketBeat

BioMarin (BMRN) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Singapore News

pulisher
Yahoo Singapore News

BioMarin Pharmaceutical (BMRN) Stock Forecast and Price Target 2024 - MarketBeat

pulisher
MarketBeat

6911 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Los Angeles Capital Management LLC - Defense World

pulisher
Defense World

Natixis Advisors L.P. Reduces Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

pulisher
Defense World

Fisher Asset Management LLC Acquires New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

pulisher
MarketBeat

What Can We Conclude About BioMarin Pharmaceutical's (NASDAQ:BMRN) CEO Pay? - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

13266 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Acquired by Fisher Asset Management LLC - Defense World

pulisher
Defense World

International Assets Investment Management LLC Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ ... - Defense World

pulisher
Defense World

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

pulisher
MarketBeat

(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest - Biomarin Pharmaceutical (NASDAQ:BMRN) - Benzinga

pulisher
Benzinga

Why You Shouldn't Bet Against BioMarin Pharmaceutical (BMRN) Stock - Yahoo News UK

pulisher
Yahoo News UK

The 3 Best Biotech Stocks to Buy in May 2024 - InvestorPlace

pulisher
InvestorPlace

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1 ... - PR Newswire

pulisher
PR Newswire
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
大文字化:     |  ボリューム (24 時間):